This HTML5 document contains 155 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1200/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33402713
rdf:type
wikibase:Item
schema:description
2012年论文 2012年论文 artículu científicu espublizáu en 2012 מאמר מדעי vědecký článek articol științific teaduslik artikkel 2012 թվականի օգոստոսին հրատարակված գիտական հոդված 2012年论文 2012年論文 article scientific artikulong pang-agham vitskapeleg artikkel 2012 nî lūn-bûn artigo científico (publicado na 2012) wetenschappelijk artikel article científic 2012年の論文 tieteellinen artikkeli videnskabelig artikel (udgivet 2012) научни чланак наукова стаття, опублікована в серпні 2012 مقالهٔ علمی ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ bilimsel makale 2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած vitenskapelig artikkel artículo científico publicado en 2012 vedecký článok 2012年論文 научная статья научни чланак artikull shkencor artykuł naukowy artigo científico (publicado na 2012) tudományos cikk scienca artikolo 2012年论文 artigo científico mokslinis straipsnis naučni članak bài báo khoa học articolo scientifico سائنسی مضمون სამეცნიერო სტატია 2012년 논문 vetenskaplig artikel 2012年论文 2012年論文 article scientifique (publié 2012) scientific article επιστημονικό άρθρο wissenschaftlicher Artikel научна статия 2012年論文 2012年论文 2012年論文 мақолаи илмӣ مقالة علمية บทความทางวิทยาศาสตร์ мақолаи илмӣ
p:P577
wds:Q33402713-93C6C90B-8CDB-4384-BBF4-1A59C33D2BCD
wdt:P577
2012-08-06T00:00:00Z
p:P407
wds:Q33402713-B09A8067-E4BF-414D-A6AE-B3ABE9A87587
wdt:P407
wd:Q1860
p:P2093
wds:Q33402713-0256F268-6232-4A12-893F-45B4D62E652F wds:Q33402713-1107DE55-B6A4-4AAC-8FC4-06A6A066F100 wds:Q33402713-1AD90507-7BFE-4EC3-9F10-3DE5D9A526CF wds:Q33402713-29837790-B1AE-4805-AC4D-97809ABD3EE4 wds:Q33402713-2B60CEB6-A9D7-48CB-AFB0-0DFD3199B57E wds:Q33402713-21FA92B9-C38D-4BA5-A4A2-33099AA37202 wds:Q33402713-22187022-3B1D-4B26-8F3B-A6094487D874 wds:Q33402713-3BFD650B-DC5D-46FC-BBCB-14651968789D wds:Q33402713-2BC28F76-A9E0-4216-A042-D94D8FB28860 wds:Q33402713-8C6B39E7-4111-4D0E-8B05-5258589B5B31 wds:Q33402713-E9C5F812-2B66-44FD-A43A-0D44F3D80F7D wds:Q33402713-9C4881B8-4BD2-4CCC-A619-4CD44F3CA510 wds:Q33402713-F9FB14E1-E5EB-4FFF-AB0C-DFFC3E38F7C1 wds:Q33402713-F26DE364-E837-49EC-ACA9-FE2DF274C989 wds:Q33402713-B847D41F-2B55-45E6-873B-56FD495B5732 wds:Q33402713-F5CF1B3E-9494-48EB-82DA-5037818C65BF wds:Q33402713-FA40A391-A68C-4D86-949D-15FC9403AFB0
wdt:P2093
Jöerg Schubert Kirsten Fischer Michael Kneba Dirk Winkler Sebastian Böttcher Andreas Bühler Matthias Ritgen Peter Staib Susanne Isfort Karl H Pflüger Anna-Maria Fink Paula Cramer Silke Schott Barbara F Eichhorst Karl-Anton Kreuzer Julia von Tresckow Raymonde Busch
rdfs:label
Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group
skos:prefLabel
Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group
schema:name
Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group
p:P50
wds:Q33402713-6351D032-2009-4F2B-95A3-C3BDDB578716 wds:Q33402713-6B402536-CB3E-4C2F-9F00-E28F23B530DD wds:Q33402713-D80E0038-ABE7-4CE8-AD74-4609AAD7A216 wds:Q33402713-E2F066EB-9A41-4F51-B837-B0F0694647D2 wds:Q33402713-F88DBDE8-6090-4646-AAA3-A16573862923 wds:Q33402713-01F5D873-CF2E-4CFA-B38E-2607149E4841
wdt:P50
wd:Q47158807 wd:Q47158775 wd:Q20752664 wd:Q47158799 wd:Q66385451 wd:Q108428543
p:P1476
wds:Q33402713-C0EF80FE-BE32-4250-8779-420B4D1048AA
wdt:P1476
Bendamustine in combination with rituximab for previously untreated patients with chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group
p:P304
wds:Q33402713-C9BB17A2-B073-4FF2-B239-09B7A6312FB7
wdt:P304
3209-3216
p:P31
wds:Q33402713-A3D19F2A-B94A-42F2-AA30-6D1E7BD81888
wdt:P31
wd:Q13442814
p:P921
wds:Q33402713-F1FE0BF9-4A35-465D-8851-2AF8C1BE8A80 wds:Q33402713-A586CFFB-843A-449E-83F8-CAD555C070FA wds:Q33402713-D4064090-E22C-4208-A3F5-A07031CCD5CB wds:Q33402713-5EB96348-38CB-441B-980F-10DE83CC31D9 wds:Q33402713-819DDC23-E612-49C6-97FB-D9A6E63B9C66 wds:Q33402713-00217005-A277-479B-AFE5-B316F93BB1B9 wds:Q33402713-0299EB07-1926-42BF-9732-03D36ECFA31F wds:Q33402713-0EAE1A14-5F39-42AE-BAD9-0E23DADDCBE2
wdt:P921
wd:Q42824440 wd:Q6934595 wd:Q29496 wd:Q1088156 wd:Q715347 wd:Q425745 wd:Q412323 wd:Q181600
p:P698
wds:Q33402713-6EEEFD08-319B-47ED-8086-CD9EE631C36E
wdtn:P698
n10:22869884
wdt:P698
22869884
p:P1433
wds:Q33402713-0C8F9A80-B7BF-4E42-BD55-2733C9478023
wdt:P1433
wd:Q400292
p:P433
wds:Q33402713-653B7697-8E46-418D-93CB-E73399AC43FD
p:P478
wds:Q33402713-450414BB-F7F8-4D4A-BB80-397D1B94A384
wdt:P433
26
wdt:P478
30
p:P356
wds:Q33402713-3BA1047F-2813-4556-B714-1696C5E6B47E
wdtn:P356
n11:JCO.2011.39.2688
wdt:P356
10.1200/JCO.2011.39.2688